サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1413215

医薬品グリセリン市場：用途別、供給源別-2024-2030年の世界予測

Pharmaceutical Glycerine Market by Utility (Care Products, Excipient), Source (Animal, Plant) - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 182 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
医薬品グリセリン市場：用途別、供給源別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 182 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医薬品グリセリン市場規模は2023年に3,747万米ドルと推定され、2024年には3,940万米ドルに達すると予測され、CAGR 5.94%で2030年には5,613万米ドルに達すると予測されます。

医薬品グリセリンの世界市場

主な市場の統計
基準年[2023］ 3,747万米ドル
予測年[2024] 3,940万米ドル
予測年 [2030] 5,613万米ドル
CAGR（%） 5.94%
医薬品グリセリン Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは医薬品グリセリン市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、医薬品グリセリン市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-医薬品グリセリン市場の市場規模および予測は？

2-医薬品グリセリン市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-医薬品グリセリン市場における技術動向と規制の枠組みは？

4-医薬品グリセリン市場における主要ベンダーの市場シェアは？

5-医薬品グリセリン市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 医薬品の賦形剤としての使用の増加
      • 天然成分の採用の増加
      • 眼圧症状の治療における応用の増加
    • 抑制要因
      • 医薬品グリセリンの悪影響
    • 機会
      • 医薬品グリセリンを開発するための研究開発活動の活発化
      • サプライチェーンと流通ネットワークの改善
    • 課題
      • 低コストの代替品の入手可能性
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 医薬品グリセリン市場ユーティリティ別

  • ケア製品
  • 賦形剤

第7章 医薬品グリセリン市場：ソース別

  • 動物
  • 植物

第8章 南北アメリカの医薬品グリセリン市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の医薬品グリセリン市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの医薬品グリセリン市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第12章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Archer Daniels Midland Company
    • Emery Oleochemicals Group
    • Fisher Scientific Co. L.L.C.
    • GJ Chemical
    • Godrej Group
    • Merck KGaA
    • Munzer Bioindustrie GmbH
    • Oleon NV
    • Pon Pure Chemicals Group
    • Procter and Gamble Company
    • Reagents
    • Renewable Energy Group Inc.
    • Sulzer Ltd
    • The Chemical Company
    • Viterra Magdeburg GmbH
  • 主要な製品ポートフォリオ

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. PHARMACEUTICAL GLYCERINE MARKET RESEARCH PROCESS
  • FIGURE 2. PHARMACEUTICAL GLYCERINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. PHARMACEUTICAL GLYCERINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. PHARMACEUTICAL GLYCERINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. PHARMACEUTICAL GLYCERINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. PHARMACEUTICAL GLYCERINE MARKET DYNAMICS
  • FIGURE 7. PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2023 VS 2030 (%)
  • FIGURE 8. PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 10. PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. PHARMACEUTICAL GLYCERINE MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. PHARMACEUTICAL GLYCERINE MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL GLYCERINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. PHARMACEUTICAL GLYCERINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 6. PHARMACEUTICAL GLYCERINE MARKET SIZE, BY CARE PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. PHARMACEUTICAL GLYCERINE MARKET SIZE, BY EXCIPIENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 9. PHARMACEUTICAL GLYCERINE MARKET SIZE, BY ANIMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. PHARMACEUTICAL GLYCERINE MARKET SIZE, BY PLANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. AMERICAS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 12. AMERICAS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 14. ARGENTINA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 15. ARGENTINA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 16. BRAZIL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 17. BRAZIL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 18. CANADA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 19. CANADA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 20. MEXICO PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 21. MEXICO PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 22. UNITED STATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 23. UNITED STATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 25. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 26. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. AUSTRALIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 29. AUSTRALIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 30. CHINA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 31. CHINA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 32. INDIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 33. INDIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 34. INDONESIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 35. INDONESIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 36. JAPAN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 37. JAPAN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 38. MALAYSIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 39. MALAYSIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 40. PHILIPPINES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 41. PHILIPPINES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 42. SINGAPORE PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 43. SINGAPORE PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 44. SOUTH KOREA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 45. SOUTH KOREA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 46. TAIWAN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 47. TAIWAN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 48. THAILAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 49. THAILAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 50. VIETNAM PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 51. VIETNAM PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 52. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 53. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. DENMARK PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 56. DENMARK PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 57. EGYPT PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 58. EGYPT PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 59. FINLAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 60. FINLAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 61. FRANCE PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 62. FRANCE PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 63. GERMANY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 64. GERMANY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 65. ISRAEL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 66. ISRAEL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 67. ITALY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 68. ITALY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 69. NETHERLANDS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 70. NETHERLANDS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 71. NIGERIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 72. NIGERIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 73. NORWAY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 74. NORWAY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 75. POLAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 76. POLAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 77. QATAR PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 78. QATAR PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 79. RUSSIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 80. RUSSIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 81. SAUDI ARABIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 82. SAUDI ARABIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 85. SPAIN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 86. SPAIN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 87. SWEDEN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 88. SWEDEN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 89. SWITZERLAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 90. SWITZERLAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 91. TURKEY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 92. TURKEY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED ARAB EMIRATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED ARAB EMIRATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED KINGDOM PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED KINGDOM PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 97. PHARMACEUTICAL GLYCERINE MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 98. PHARMACEUTICAL GLYCERINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 99. PHARMACEUTICAL GLYCERINE MARKET LICENSE & PRICING
目次
Product Code: MRR-742BD5183839

[182 Pages Report] The Pharmaceutical Glycerine Market size was estimated at USD 37.47 million in 2023 and expected to reach USD 39.40 million in 2024, at a CAGR 5.94% to reach USD 56.13 million by 2030.

Global Pharmaceutical Glycerine Market

KEY MARKET STATISTICS
Base Year [2023] USD 37.47 million
Estimated Year [2024] USD 39.40 million
Forecast Year [2030] USD 56.13 million
CAGR (%) 5.94%
Pharmaceutical Glycerine Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Pharmaceutical Glycerine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pharmaceutical Glycerine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Glycerine Market, highlighting leading vendors and their innovative profiles. These include Archer Daniels Midland Company, Emery Oleochemicals Group, Fisher Scientific Co. L.L.C., GJ Chemical, Godrej Group, Merck KGaA, Munzer Bioindustrie GmbH, Oleon NV, Pon Pure Chemicals Group, Procter and Gamble Company, Reagents, Renewable Energy Group Inc., Sulzer Ltd, The Chemical Company, and Viterra Magdeburg GmbH.

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Glycerine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Utility
    • Care Products
    • Excipient
  • Source
    • Animal
    • Plant
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Pharmaceutical Glycerine Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pharmaceutical Glycerine Market?

3. What are the technology trends and regulatory frameworks in the Pharmaceutical Glycerine Market?

4. What is the market share of the leading vendors in the Pharmaceutical Glycerine Market?

5. Which modes and strategic moves are suitable for entering the Pharmaceutical Glycerine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Pharmaceutical Glycerine Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing usage as excipients in pharmaceutical preparations
      • 5.1.1.2. Rising adoption of natural ingredients
      • 5.1.1.3. Increasing application in the treatment of eye pressure conditions
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse effects of pharmaceutical glycerine
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising R&D activities to develop pharmaceutical glycerine
      • 5.1.3.2. Improvements in supply chain and distribution network
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of low cost substitutes
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Pharmaceutical Glycerine Market, by Utility

  • 6.1. Introduction
  • 6.2. Care Products
  • 6.3. Excipient

7. Pharmaceutical Glycerine Market, by Source

  • 7.1. Introduction
  • 7.2. Animal
  • 7.3. Plant

8. Americas Pharmaceutical Glycerine Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Pharmaceutical Glycerine Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Pharmaceutical Glycerine Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Archer Daniels Midland Company
    • 12.1.2. Emery Oleochemicals Group
    • 12.1.3. Fisher Scientific Co. L.L.C.
    • 12.1.4. GJ Chemical
    • 12.1.5. Godrej Group
    • 12.1.6. Merck KGaA
    • 12.1.7. Munzer Bioindustrie GmbH
    • 12.1.8. Oleon NV
    • 12.1.9. Pon Pure Chemicals Group
    • 12.1.10. Procter and Gamble Company
    • 12.1.11. Reagents
    • 12.1.12. Renewable Energy Group Inc.
    • 12.1.13. Sulzer Ltd
    • 12.1.14. The Chemical Company
    • 12.1.15. Viterra Magdeburg GmbH
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing